Related Experiment Video

Updated: Jan 2, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.3K

[Austrian Consensus on High Blood Pressure 2019]

Thomas Weber1, Klaus Arbeiter2, Florian Ardelt3

  • 1Abteilung für Innere Medizin II - Kardiologie, Intensivmedizin, Klinikum Wels-Grieskirchen, Grieskirchnerstraße 42, 4600, Wels, Österreich.

Wiener Klinische Wochenschrift
|December 4, 2019
PubMed

Insights

High blood pressure is a major health concern in Austria. This national consensus aims to standardize hypertension management, improving patient outcomes and reducing cardiovascular disease burden.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Elevated blood pressure is a leading cause of cardiovascular disease, disability, and premature death in Austria.
  • Current rates of hypertension detection, treatment, and control remain suboptimal.
  • Managing hypertension presents a significant challenge for physicians across various specializations.

Purpose of the Study:

  • To standardize diagnostic and therapeutic strategies for hypertension in Austria.
  • To increase the rate of patients with controlled blood pressure.
  • To decrease the burden of cardiovascular disease associated with uncontrolled hypertension.

Main Methods:

  • A comprehensive review of existing evidence on the prevention, detection, workup, treatment, and consequences of high blood pressure.
  • Involvement of 13 Austrian medical societies in the evidence review process.
  • Development of the first national consensus on blood pressure management.

Main Results:

  • The consensus provides standardized guidelines for hypertension management.
  • It addresses general high blood pressure and specific clinical scenarios.
  • The document represents a unified national approach to tackling hypertension.

Conclusions:

  • A joint national effort is crucial to reduce hypertension-related morbidity and mortality in Austria.
  • Standardized strategies are expected to improve blood pressure control rates.
  • The consensus serves as a foundation for enhanced cardiovascular disease prevention.

Keywords:
Arterial HypertensionBlood PressureGuidelinesTreatment

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.9K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.3K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
526
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
407
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
626
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
676